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INTRODUCTION
The mechanisms underlying angiogenesis have been extensively studied for the past forty years, resulting in an enhanced understanding of the complex cellular processes that together initiate and sustain angiogenesis and generating therapeutically important molecular targets (Carmeliet and Jain, 2011; Coultas et al, 2005 ; Ferrara and Kerbel,
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subunits that belong to the family of inwardly rectifying potassium (K ir ) channels (Flagg et al., 2010) . The two subtypes found in K ATP , K ir 6.1 and K ir 6.2, are encoded respectively by the KCNJ8 and KCNJ11 genes and are thought to be inhibited by rises in cytosolic ATP (Flagg et al., 2010) . K ATP are widely distributed in many tissues and cell types, including pancreatic JPET #222000 6 To evaluate the angiogenic effects of K ATP modulation and assess the endothelial effects of CNP, we used both a classic in vivo angiogenesis model (chick embryo chorioallantoic membrane, CAM), together with in vitro cell-based assays (proliferation, migration, cord-like network formation on Matrigel), using two different populations of endothelial cells: mouse bEnd.3 (Suzuki et al., 2011) and HUVECs. Collectively, our data suggest that K ATP stimulation, either directly, using K ATP openers, or indirectly, via VEGF-or CNP-originated signaling, can induce endothelial angiogenic responses which depend on the presence of the K ir 6.1 K ATP subunit. K ATP modulation, therefore, offers a new means to pharmacologically interfere with angiogenesis and constitutes a novel therapeutic target in angiogenesis.
8 Human umbilical endothelial cells (HUVEC) were isolated from cords obtained according to clinical consent agreement protocols and grown on gelatinized dishes in M199 supplemented with 15 % fetal calf serum, 50 U/ml penicillin, 50 μ g/ml streptomycin, 50 μ g/ml gentamycin, 2.5 μ g/ml amphotericin B, 5 U/ml heparin and 150-200 μ g/ml endothelial cell growth supplement. Cells were used between passages 1 and 3. Each experiment shown derives from 3 independent repeats, each time using different pools (isolates) and/or passages of cells.
In vivo chick chorioallantoic membrane assay (CAM)
White Leghorn chicken eggs were placed in an incubator as soon as embryogenesis started (day 0) and kept under constant humidity at 37 o C. On day 4, a square window was opened in the shell and then sealed with adhesive tape. On day 9, an O-ring (1 cm 2 ) was placed on the surface of the CAM and the various treatments were added inside this restricted area as previously described (Papapetropoulos et al., 2009) . After 48 h, CAMs were fixed in Carson's solution (saline-buffered formalin) and angiogenesis was evaluated using image analysis software. For the CAM experiments, 30-35 eggs were used per group distributed in 3 independent experiments. Handling and use of chick embryos was performed according to University of Patras institutional animal welfare protocols.
Cell transfection with small interfering RNAs (siRNAs)
HUVECs were treated either with Vehicle (Vehicle CTL) or were transfected with siRNAs. The siRNA final concentrations used were 14nM for the Ambion siRNAs and 40nM for the Santa Cruz siRNAs. We used two different Control siRNAs: Cat#sc-37007 from Santa Cruz (Heidelberg, Germany), referred to as CTLsi#1 and Cat#4390843 from JPET #222000 Ambion (Carlsbad, USA), referred to as CTLsi#2 and two different siRNAs targeting specifically the K ir 6.1 K ATP channel subunit: Cat#sc-35752 from Santa Cruz, referred to as K ir 6.1si#1 and Cat#4392420 from Ambion, referred to as K ir 6.1si#2. Four hours later the transfection medium was replaced by fresh medium and cells were allowed to grow for another 20 hours. At the end of this incubation time, cells were washed twice with PBS, trypsinized and used in migration and Matrigel assays. RNA was also collected for qRT-PCR and cell lysates were collected for western blotting experiments.
Transwell migration assay
The capacity of endothelial cells to migrate through a pore-bearing membrane was assessed using 6.5 mm diameter Transwell chambers with polycarbonate membrane 
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1 0 At the end of this incubation time, cells were trypsinized and their number was determined using a Neubauer hemocytometer.
Quantitative reverse-transcription -polymerase chain reaction (qRT-PCR)
mRNA expression was evaluated using Real-Time Quantitative RT-PCR (qRT-PCR).
Total cellular RNA was isolated using the RNeasy Mini Kit (Qiagen, Germany) and quantified by a NanoDrop 2000 (Thermo Scientific, USA). 250 ng of total RNA were subjected to reverse transcription and real time PCR amplification using the KAPA SYBR Fast One-step qRT-PCR protocol (KapaBiosystems). Amplification and RealTime fluorescence detection was performed using the Rotor Gene 6000 (Corbett, USA).
Each of the PCR amplification reactions was set up in triplicate. Forward and reverse 
Western blotting
Protein extracts from HUVECs were separated by SDS-PAGE electrophoresis and transferred to a PVDF membrane as previously described ( 
Statistical Analysis
Data are expressed as the mean ± SEM of the given number of observations. Results were compared between groups using Student's t-tests using SPSS 10.0 software (IBM, Armonk, NY) under Windows XP. A p value of <0.05 was considered to be significant.
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RESULTS
SG-209 and CNP promote in vivo chick CAM angiogenesis
To determine whether K ATP activation elicits angiogenic responses, we first tested in the CAM angiogenesis model a direct channel opener, the Nicorandil derivative SG-209. We next tested whether receptor-mediated K ATP activation by CNP participates in similar in vitro responses. CNP (1-1000pM) dose-dependently increased cell proliferation (maximal effect: 38.2±5.9% increase at 1000pM, Fig 4A) , an effect comparable to that elicited in parallel by 500pM VEGF (increase of 49.9±7.5%, Fig. 4A ). The proliferative effects of VEGF were almost entirely suppressed by the K ATP blockers Glibenclamide and 5-HD (Fig 4B) . CNP (100pM) and VEGF (500pM) also induced comparable
SG-209 lacks
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In subsequent experiments, we transfected HUVECs with either a Control siRNA or a siRNA specific for K ir 6.1 for 24h and determined their responses in Transwell migration and Matrigel assays. CNP (100pM) alone produced 3-fold increases above basal in cell migration (Fig. 7A ). These increases were markedly suppressed (83% reduction of CNP's effect) by K ir 6.1siRNA, while the Control siRNA had only a small, although significant, effect (Fig. 7A) . Similarly, in the Matrigel assay, cord network formation induced by SG-209 (1µM, 134±3.5% increase above Vehicle Control) or by CNP (100pM, 158±2.4% increase above basal) was reduced to 18±3.8% and 17.3±4.2%
above Control respectively, in cells transfected with the K ir 6.1-specific siRNA (Fig.7B ).
This result points to a required role of K ir 6.1 in the effects of both angiogenic molecules.
Identical results were obtained when a second K ir 6.1siRNA was used (Supplementary In bEnd.3 cells, proliferation and migration were promoted by direct K ATP openers (Fig.   3 ). Nicorandil seemed more effective in promoting migration/motility than its derivative, SG-209 (Fig. 3B) . This is unlikely due to the additional ability of Nicorandil to "donate" NO, since K ATP inhibitors reduced equally the effects of both agents ( be noted that the activators' proliferative effect depends on the specific cell type under study (Zuo et al., 2011) .
Endothelial proliferation and motility were comparably increased by CNP and VEGF (Fig. 4) and abrogated by K ATP inhibition ( Fig. 4B and C Taken together, our data support a bona fide regulatory role for K ATP in angiogenesis, begging the question of their molecular composition and their cellular localization. K ATP composition varies, based on the specific expression of the regulatory (sulfonylureabinding, SUR) and the pore-forming (inwardly rectifier, K ir ) subunits (Aschcroft, 1988; Flagg et al., 2010) , resulting in different nucleotide sensitivities and pharmacological sensitivity. Cardiomyocyte K ATP are composed of SUR2A and K ir 6.2, while in smooth muscle cells they are formed by SUR2B and K ir 6.1 (Seino and Miki, 2003) . In the coronary and other endothelia, where ATP-sensitive potassium channels are known to be present (Janigro et al., 1993; Mederos y Schnitzler et al., 2000) , SUR2B is combined with both K ir 6.1 and K ir 6.2 subunits (Yoshida et al., 2004) . In agreement with Yoshida et al., we have been able to detect both K ir 6.1 (this study) and K ir 6.2 (B. Umaru, unpublished observations) subunits in HUVECs by qPCR and western blotting analysis.
The cord-like network formation elicited by SG-209 or CNP (Fig. 7) in HUVECs required unperturbed expression of the K ir 6.1 subunit (Fig. 6, Fig.7) , suggesting a) participation of K ir 6.1 in these responses and b) existence of a K ir 6.1 "expression-dosage"-sensitive , 2004; Sato et al., 1998) , to antagonize the functional responses of direct or indirect K ATP activation as effectively as the non-selective inhibitor Glibenclamide (Fig. 3-6) , combined with the dependence of these responses on the expression of K ir 6.1 (Fig. 7) , suggest that mitoK ATP , comprising K ir 6.1 subunits, are key mediators of angiogenesis and may underpin the endothelial-protective effects of both 
